Unlocking the Power of Systems Thinking in Policymaking: A Path to Stronger Health Systems

By HEOR Staff Writer

July 3, 2023

Discover the untapped potential of systems thinking in shaping effective policies and practices published in a new article. 

Traditionally seen as too conceptual for policy relevance, systems thinking is now gaining traction in high-income countries, with governments embracing adaptive leadership and systemic evaluations. 

But what about low- and middle-income countries? Resource constraints often hinder the institutionalization of systems thinking, making it challenging to replicate successful examples.

To overcome this, the study proposes three key steps:

1️⃣ Theorise and clarify the terminology of applied systems thinking in health policy and systems research (HPSR). By utilising systems modeling and other tools, we can better understand the interactions between interventions and their contexts. 

2️⃣ Encourage greater government investment and institutional incentives to foster long-term collaboration and science-policy partnerships. This will enhance the capacities and practice of systems thinking in policymaking. 

3️⃣ Advocate for funding norms that enable systems thinking in LMICs. Pooling resources and fostering networked institutions can address complexity and adaptive approaches, leading to more impactful outcomes. 

 

To read the full article click on the link below. 

Reference url

Recent Posts

FDA Confirms GLP-1 RA Safety Review: No Increased Suicidal Risk

By HEOR Staff Writer

February 2, 2026

GLP-1 RA Safety Review Clears Suicidal Risk Concerns In a pivotal GLP-1 RA safety review, the U.S. Food and Drug Administration (FDA) has concluded, following an extensive analysis of clinical and real-world data, that glucagon-l...
Latin America Pharma Growth: Boehringer Ingelheim’s Strategic Investments and Trends

By HEOR Staff Writer

January 27, 2026

Latin America Pharma Growth is surging as a high-growth engine for Boehringer Ingelheim, with double-digit market expansions outpacing mature regions like Europe, according to D...
FDA Updates Labeling on Febrile Seizure Risks in Influenza Vaccine for Children

By João L. Carapinha

January 19, 2026

FDA Labeling Mandate on Febrile Seizure Risks In a significant update to vaccine safety protocols, the U.S. Food and Drug Administration (FDA) has required pediatric influenza vaccines to include warnings about an elevated risk of febri...